Poznyak et al., 2020), glucose transporter defect, amyloid formation for -cell dysfunction (Eizirik et al., 2020), OS (Dos Santos et al., 2019), mitochondrial dysfunction, excess fatty acid, or lack of the cretin effect (Galicia-Garcia et al., 2020)
Daily administration of setmelanotide in these studies resulted in notable reductions in hunger and significant weight loss
Alcohol itself can cause gastritis and gastrointestinal irritation, potentially compounding the gastrointestinal side effects of GLP-1 medications
Current management strategies mainly involve the use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), biological DMARDs, and targeted synthetic DMARDs combined with glucocorticoids to alleviate inflammation and pain [3]